Sofosbuvir

A revolutionary antiviral drug called sofosbuvir is a member of the DAA (direct-acting antiviral) class of drugs. It offers patients all around the world a very efficient and well-tolerated therapeutic alternative for the treatment of chronic hepatitis C virus (HCV) infection. This amazing medication works by specifically targeting the RNA-dependent RNA polymerase, an enzyme involved in the reproduction of the HCV virus. Sofosbuvir efficiently interferes with the virus's capacity to reproduce and propagate throughout the body by blocking this crucial enzyme. They are appropriate for a variety of individuals, including those with concomitant illnesses or liver cirrhosis.